AsOf

AstraZeneca · revenue58,739,000,000 United States dollar

valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted

What the statuses mean

Valid from
2025-12-31
Valid until
still holds
Published
2026-02-24
Recorded by AsOf
2026-11-08
Checked
2026-11-08 · parsed from the SEC filing
Confidence
0.95

Sources

Cite this claim

Each form names the value, its as-of date (2025-12-31), the day you read it (2026-11-09), the claim's stable URL and id and its primary source. The URL never changes: a superseded claim stays at the same address.

Plain text
AsOf. "AstraZeneca revenue: 58,739,000,000 United States dollar", as of 2025-12-31. Claim clm_75285D1846DF, https://asof.is/claim/clm_75285D1846DF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm.
APA
AsOf. (2025). AstraZeneca revenue: 58,739,000,000 United States dollar (as of 2025-12-31) [Record clm_75285D1846DF]. Retrieved November 9, 2026, from https://asof.is/claim/clm_75285D1846DF (source: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm)
BibTeX
@misc{asof_clm_75285D1846DF,
  author = {AsOf},
  title = {AstraZeneca revenue: 58,739,000,000 United States dollar},
  year = {2025},
  howpublished = {\url{https://asof.is/claim/clm_75285D1846DF}},
  note = {Claim clm\_75285D1846DF, as of 2025-12-31; source: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm},
  urldate = {2026-11-09}
}

Supersedes

On the record

/claim/clm_75285D1846DF.md/v1/claims/clm_75285D1846DFsubmit a correction